Researchers studying hepatitis, liver cancer, transplants and gall bladder disease will gather here tomorrow for the annual meeting of American Association for the Study of Liver Disease.
They call it simply “The Liver Meeting” and the tend to meet in Boston. Here’s a peak at what are being billed as "State of the Art Lectures’
|
Hans Popper Basic Science State-of-the-Art Lecture |
Goal and Objective:
- Discuss recent work that led to the discovery that bile acids are not only acting as detergents that solubilize nutrients in the gut, but they are also important endocrine signaling molecules that affect many metabolic processes, going from the control of energy homeostasis and
body weight, to a role in glucose metabolism
|
Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture |
Goal and Objective:
- Explore various therapeutic options for HCC including surgical alternatives
|
Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture |
Goals and Objectives:
- Learn about the innate immune system’s role as it relates to liver health and development of acute and chronic liver diseases
- Understand the basic cellular and molecular mechanisms of the innate immune system in relation to liver disease pathogenesis
|
Leon Schiff State-of-the-Art Lecture |
Goals and Objectives:
- Learn how human genetics research has the capability to deliver clinically meaningful findings that can have immediate applications to the treatment of disease
- Discuss a recent study by Dr. Goldstein and colleagues that reported a causal effect of a genetic variant in the treatment of hepatitis C